Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 5422

1.

Safety and Efficacy of a Once-Daily Halobetasol Propionate 0.01% Lotion in the Treatment of Moderate-to-Severe Plaque Psoriasis: Results of Two Phase 3 Randomized Controlled Trials.

Green LJ, Kerdel FA, Cook-Bolden FE, Bagel J, Lin T, Martin G, Pillai R, Israel R, Ramakrishna T.

J Drugs Dermatol. 2018 Oct 1;17(10):1062-1069.

PMID:
30365586
3.

Establishing an Efficient Care Paradigm for Trigger Finger.

Usmani RH, Abrams SS, Merrell GA.

J Hand Surg Asian Pac Vol. 2018 Sep;23(3):356-359. doi: 10.1142/S2424835518500364.

PMID:
30282540
4.

[Black henna tattoo: risk of developing allergic contact eczema].

Anzi OE, Hassam B.

Pan Afr Med J. 2018 May 18;30:46. doi: 10.11604/pamj.2018.30.46.15563. eCollection 2018. French.

6.

Neurophysiological correlates of clinical improvement after greater occipital nerve (GON) block in chronic migraine: relevance for chronic migraine pathophysiology.

Viganò A, Torrieri MC, Toscano M, Puledda F, Petolicchio B, Sasso D'Elia T, Verzina A, Ruggiero S, Altieri M, Vicenzini E, Schoenen J, Di Piero V.

J Headache Pain. 2018 Aug 20;19(1):73. doi: 10.1186/s10194-018-0901-z.

7.

Patient-Reported Satisfaction With the Fixed Combination Calcipotriene/Betamethasone Dipropionate Foam for Plaque Psoriasis.

Gorelick J, Cantrell W, Kucera K, Veverka KA, Gooding K.

J Drugs Dermatol. 2018 Aug 1;17(8):880-884.

PMID:
30124727
8.

Rapid Onset of Action in Patients With Moderate-to-Severe Plaque Psoriasis With Halobetasol 0.01%/Tazarotene 0.045% Fixed Combination.

Stein Gold L, Kircik LH, Pariser D, Sugarman JL, Lin T, Kang R, Pillai R.

J Drugs Dermatol. 2018 Aug 1;17(8):863-868.

PMID:
30124725
9.

Safety and Efficacy of a Fixed Combination Halobetasol and Tazarotene Lotion in the Treatment of Moderate-to-Severe Plaque Psoriasis: A Pooled Analysis of Two Phase 3 Studies.

Sugarman JL, Weiss J, Tanghetti EA, Bagel J, Yamauchi PS, Stein Gold L, Lin T, Martin G, Pillai R, Israel R.

J Drugs Dermatol. 2018 Aug 1;17(8):855-861.

PMID:
30124724
11.

Paraneoplastic granulomatous dermatitis in a patient with Hodgkin's disease: a diagnostic pitfall.

Tabata MM, Novoa RA, Martires KJ.

BMJ Case Rep. 2018 Aug 11;2018. pii: bcr-2018-224961. doi: 10.1136/bcr-2018-224961.

PMID:
30100570
12.

The Evolution of Topical Formulations in Psoriasis.

Kuehl B, Shear NH.

Skin Therapy Lett. 2018 Jul;23(4):5-9. Review.

13.
14.

An early post-operative ACTH suppression test can safely predict short- and long-term remission after surgery of Cushing's disease.

Uvelius E, Höglund P, Valdemarsson S, Siesjö P.

Pituitary. 2018 Oct;21(5):490-498. doi: 10.1007/s11102-018-0902-6.

16.

Halobetasol 0.01%/Tazarotene 0.045% Lotion in the Treatment of Moderate-to-Severe Plaque Psoriasis: Maintenance of Therapeutic Effect After Cessation of Therapy.

Pariser DM, Green LJ, Stein Gold L, Sugarman JL, Lin T, Pillai R.

J Drugs Dermatol. 2018 Jul 1;17(7):723-726.

PMID:
30005093
17.

Tamsulosin-induced photosensitivity rash.

Tan CK, Yap KB.

Singapore Med J. 2018 Jun;59(6):336-337. doi: 10.11622/smedj.2018072. No abstract available.

18.

Greater improvement in quality of life outcomes in patients using fixed-combination calcipotriol plus betamethasone dipropionate aerosol foam versus gel: results from the PSO-ABLE study.

Griffiths CE, Stein Gold L, Cambazard F, Kalb RE, Lowson D, Møller A, Paul C.

Eur J Dermatol. 2018 Jun 1;28(3):356-363. doi: 10.1684/ejd.2018.3302.

PMID:
29952297
19.

The Hypothalamic-Pituitary-Adrenal Axis and the Fetus.

Morsi A, DeFranco D, Witchel SF.

Horm Res Paediatr. 2018;89(5):380-387. doi: 10.1159/000488106. Epub 2018 Jun 6. Review.

PMID:
29874660
20.

Intramuscular versus oral corticosteroids to reduce relapses following discharge from the emergency department for acute asthma.

Kirkland SW, Cross E, Campbell S, Villa-Roel C, Rowe BH.

Cochrane Database Syst Rev. 2018 Jun 2;6:CD012629. doi: 10.1002/14651858.CD012629.pub2. Review.

PMID:
29859017

Supplemental Content

Loading ...
Support Center